Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
474.1 INR | -0.41% | -6.04% | -3.09% |
May. 06 | Transcript : Aarti Drugs Limited, Q4 2024 Earnings Call, May 06, 2024 | |
May. 03 | Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Sales 2024 | 25.29B 303M | Sales 2025 * | - | Capitalization | 43.61B 523M |
---|---|---|---|---|---|
Net income 2024 | 1.71B 20.55M | Net income 2025 * | 2.38B 28.47M | EV / Sales 2024 | 1.58 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 |
23.4
x | P/E ratio 2025 * |
18.5
x | Employees | 1,003 |
Yield 2024 * |
0.99% | Yield 2025 * |
1.35% | Free-Float | 36.93% |
Latest transcript on Aarti Drugs Limited
1 day | -0.41% | ||
1 week | -6.04% | ||
Current month | -6.04% | ||
1 month | -3.77% | ||
3 months | -11.00% | ||
6 months | +0.89% | ||
Current year | -3.09% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 12-07-05 |
Rushikesh Deole
CMP | Compliance Officer | - | 19-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Director/Board Member | 61 | 87-01-01 | |
Director/Board Member | 60 | 95-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 474.1 | -0.41% | 75 685 |
24-05-07 | 476 | -3.07% | 120,648 |
24-05-06 | 491.2 | -2.28% | 181,104 |
24-05-03 | 502.6 | +0.36% | 97,780 |
24-05-02 | 500.8 | -0.74% | 62,037 |
Delayed Quote NSE India S.E., May 08, 2024 at 07:40 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.20% | 700B | |
-4.98% | 358B | |
+18.91% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.93% | 161B | |
-1.87% | 157B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock